Old Web
English
Sign In
Acemap
>
authorDetail
>
Don B. Axworthy
Don B. Axworthy
Chemistry
Pretargeting
Radioimmunotherapy
In vivo
Cancer research
5
Papers
105
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.
2003
Clinical Cancer Research
Scott S. Graves
Erica Dearstyne
Yukang Lin
Yuting Zuo
James Sanderson
Jody Schultz
Anastasia Pantalias
David Gray
Don B. Axworthy
H. Mark Jones
Karen Auditore-Hargreaves
Show All
Source
Cite
Save
Citations (50)
Preparation of 213bi-dota-biotin in high specific activity for pretargeted alpha radiotherapy of cancer
2001
Journal of Labelled Compounds and Radiopharmaceuticals
Mark D. Hylarides
Don B. Axworthy
Alan R. Fritzberg
Show All
Source
Cite
Save
Citations (1)
Molecular Modeling and Preclinical Evaluation of the Humanized NR-LU-13 Antibody
1999
Clinical Cancer Research
Scott S. Graves
Stephen Goshorn
Diane Stone
Don B. Axworthy
John M. Reno
Becky J. Bottino
Stephen Searle
Andrew H. Henry
Jan T. Pedersen
Anthony R. Rees
Randell T. Libby
Show All
Source
Cite
Save
Citations (11)
1